Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions

Mostrar otras versiones (2)

Many drugs that have been proposed for treatment of COVID-19 are reported to cause cardiac adverse events, including ventricular arrhythmias. In order to properly weigh risks against potential benefits, particularly when decisions must be made quickly, mathematical modeling of both drug disposition...

Descripción completa

Detalles Bibliográficos
Autores principales: Varshneya, Meera, Irurzun-Arana, Itziar, Campana, Chiara, Dariolli, Rafael, Gutierrez, Amy, Pullinger, Taylor K., Sobie, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273296/
https://www.ncbi.nlm.nih.gov/pubmed/32511528
http://dx.doi.org/10.1101/2020.05.21.20109397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273296/
https://www.ncbi.nlm.nih.gov/pubmed/32511528
http://dx.doi.org/10.1101/2020.05.21.20109397

Ejemplares similares